The epidemiology of male lower urinary tract symptoms associated with benign prostatic hyperplasia: Results of 20 years of Korean community care and surveys

• Published in: Investigative and clinical urology Vol. 65; no. 1; pp. 69 - 76
• Main Authors: Jeh, Seonguk, Choi, Minsung, Kang, Changseok, Kim, Daehyun, Choi, Jaehwi, Choi, Seemin, Hwa, Jeongseok, Lee, Chunwoo, Kam, Sungchul, Kwon, Seongwon, Kim, Saecheol, Song, Jaeman, Kwon, Dongdeuk, Kwon, Tae Gyun, Kim, Kwangho, Kim, Younggon, Kim, Taehyung, Park, Dong Soo, Park, Hyun Jun, Seong, Rakhee, Yang, Sangguk, Yoon, Seongtae, Yun, Jinhan, Lee, Gyeongseop, Lee, Donghyun, Lee, Seonju, Jeon, Byungyul, Jung, Hyunchul, Hong, Seongjun, Choi, Nakkyu, Lee, Yunsoo, Hyun, Jaeseog
• Format: Journal Article
• Language: English
• Published: Korea (South) The Korean Urological Association 01.01.2024; Korean Urological Association; 대한비뇨의학회
• Subjects: benign prostatic hyperplasia; epidemiology; Humans; korean; lower urinary tract symptoms; Lower Urinary Tract Symptoms - epidemiology; Lower Urinary Tract Symptoms - etiology; Male; Original; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia - complications; Prostatic Hyperplasia - epidemiology; Republic of Korea - epidemiology; 비뇨기과학; Republic of Korea; Benign prostatic hyperplasia; Korean; Epidemiology; Lower urinary tract symptoms
• ISSN: 2466-0493; 2466-054X; 2466-054X
• DOI: 10.4111/icu.20230249

To investigate the prevalence of lower urinary tract symptoms/benign prostatic hyperplasia in a Korean population. The Korean Prostate & Voiding Health Association provided free prostate-related community health care and conducted surveys in all regions of Korea from 2001 to 2022 with the cooperation of local government public health centers. A total of 72,068 males older than 50 were surveyed and analyzed. History taking, International Prostate Symptom Score (IPSS), transrectal ultrasonography, prostate-specific antigen (PSA) testing, uroflowmetry, and urine volume testing were performed. The mean prostate volumes in males in their 50s, 60s, 70s, and 80s or above were 24.7 g, 27.7 g, 31 g, and 33.7 g, respectively. The proportion of males with high PSA greater than 3 ng/mL was 3.8% among males in their 50s, 7.7% among males in their 60s, 13.1% among males in their 70s, and 17.9% among males 80 years of age or older. The mean IPSS total scores in males in their 50s, 60s, 70s, and 80s or above were 10.7, 12.7, 14.5, and 16, respectively. Severe symptoms were reported by 27.3% of males, whereas 51.7% reported moderate symptoms. The mean Qmax in males in their 50s, 60s, 70s, and 80s or above were 20 mL/s, 17.4 mL/s, 15.4 mL/s, and 13.8 mL/s, respectively. In this population-based study, mean prostate volume, IPSS, PSA, and Qmax were 30.6±15.1 g, 14.8±8.2, 1.9±4.7 ng/mL, and 15.6±6.5 mL/s, respectively. Aging was significantly associated with increased prostate volume, PSA levels, and IPSS scores, and with decreased Qmax and urine volume.